You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Pharmacological Aids to Promote Smoking Cessation

Feigenbaum, Janice Cooke Ph.D1

Journal of Addictions Nursing:
doi: 10.3109/10884601003777612
Original Papers/CE FEATURE
Abstract

The Agency for Healthcare Research and Quality's (Fiore et al., 2008) clinical guidelines on smoking cessation identified seven medications as first‐line drugs which have been shown to promote long‐term smoking cessation efforts. These pharmacological agents include five types of nicotine replacement therapies and two specific drugs, Buproprion SR and Varenicline. Key issues that health care professionals should address when caring for individuals who are dependent on tobacco are discussed. Barriers, such as the attitudes and knowledge of the persons who smoke and health care professionals, that impede individuals’ use of medications within their plan of smoking cessation are addressed. Special attention is given to the increase in suicide potential during the process of quitting. The need for nurses and other health care professionals to pursue research to identify the most effective ways of educating themselves to promote smoking cessation with males and females from adolescence through old age, including those with mental health and addiction disorders, is emphasized.

Author Information

1School of Nursing, University at Buffalo, Buffalo, New York, USA

Address correspondence to Dr Janice Cooke Feigenbaum, University at Buffalo, School of Nursing, Wende Hall 219, 3435 Main Street, Buffalo, New York, 14214. E‐mail: jcf6@buffalo.edu

© 2010International Nurses Society on Addictions

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.